Unknown EARLY_PHASE1 INTERVENTIONAL 2-arm NCT05943028

Effect of Subanesthetic Dose Esketamine on Propofol-refentanil Closed-loop Targeted Controlled Infusion

Chief Physician of the Department of Anesthesiology of the Southern Theater General Hospital

Sponsor: bo xu

Interventions Subanesthetic dose of esketamine

Updated 4 times since 2023 Last updated: Jul 5, 2023 Started: Jul 1, 2023 Primary completion: Oct 1, 2024 Completion: Oct 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A EARLY_PHASE1 clinical study on Esketamine, this trial is ongoing. The trial is conducted by bo xu and has accumulated 4 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Aug 2025 — Present [monthly]

Unknown EARLY_PHASE1

Status: Not Yet Recruiting → Unknown
Sep 2024 — Aug 2025 [monthly]

Not Yet Recruiting EARLY_PHASE1
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1
Aug 2023 — Jul 2024 [monthly]

Not Yet Recruiting EARLY_PHASE1

First recorded

Jul 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

bo xu

Data source: Guangzhou General Hospital of Guangzhou Military Command

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.